Latest News

BrightFocus Foundation, a nonprofit and premier source of research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, today was acknowledged as the catalyst behind a major advance in drug development for Alzheimer’s disease.

A panel of leading researchers and policy experts has released five key recommendations for public and private sector leaders to better support people with dementia living in their own home.

Ruchira Singh and colleagues at the University of Rochester and worldwide have shown that even rare forms of macular degeneration develop in ways similar to AMD, with drusen formation and extracellular proteins. The goal ahead: effective early treatment approaches.

“BrightFocus Foundation lauds today’s historic announcement by Bill Gates of his $50 million investment in the Dementia Discovery Fund. A charitable act of this magnitude is a profound example of the courage and the power of philanthropy to tackle society’s most pressing challenges."

The summer edition of the Alzheimer's Disease Research Review provides information on significant progress in understanding how tau tangles may spread in the earliest stages of Alzheimer’s disease, a study offering hope that we can decrease our risk of developing dementia, and more.

BrightFocus Foundation announced today that communications strategist Cecilia Arradaza has joined the organization’s Board of Directors.

BrightFocus Foundation has announced the awarding of research grants to three scientists at Johns Hopkins University. The grantees’ research topics reflect the three diseases of aging that the foundation is working to end: Alzheimer’s, glaucoma, and macular degeneration.

Kim Campbell talks about her journey as a caregiver, and panelists address other Alzheimer's disease issues, in this free program.